Colgate Q4 sales dip 0.1% as EPS rises 3%; 2025 sales seen roughly flat
Colgate-Palmolive reported fourth quarter and full year 2024 results. Fourth quarter net sales were $4,944 million, down 0.1%, while GAAP diluted EPS rose 3% to $0.90. For the full year, net sales reached $20.1 billion (up 3.3%) and GAAP diluted EPS rose 27% to $3.51. For 2025, the company expects roughly flat net sales and mid-single-digit GAAP EPS growth.
Key points
- Q4 2024 net sales $4,944 million, down 0.1%; organic sales up 4.3%
- Q4 2024 GAAP diluted EPS $0.90, up 3%; Base Business EPS $0.91, up 5%
- Full year 2024 net sales $20.1 billion, up 3.3%; GAAP diluted EPS $3.51, up 27%
- 2025 guidance: net sales roughly flat, including a mid-single-digit negative FX impact; GAAP EPS growth mid-single-digit
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 31, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.